AlloVir (ALVR) Stock Chart & Stock Price History $2.67 -0.04 (-1.48%) As of 08/8/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AlloVir Stock Price Performance The AlloVir (ALVR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.00%, with a year-to-date return of -72.36%. In the past month, the stock has increased 4.71%, reflecting recent market activity. As of the latest close, AlloVir traded at $2.71 with a market cap of $13.67 million and volume of 27,651 shares. Five years ago, the stock traded at a split-adjusted price of $944.15, representing a 99.72% decrease over that period. At the time, it had a market cap of $2.57 billion and a volume of 24,838 shares. Receive ALVR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.74%1 Month Performance+4.71%3 Month Performance-30.65%Year-To-Date Performance-72.36%1 Year Performance-84.00%5 Year Performance-99.72% ALVR Stock Chart for Sunday, August, 10, 2025 ALVR Chart by TradingView AlloVir Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$2.64$2.71+2.65%$2.79$2.6027,651 shs$13.67 million08/07/2025$2.55$2.64+3.53%$2.77$2.5472,103 shs$13.31 million08/06/2025$2.69$2.55-5.20%$2.68$2.4648,185 shs$12.86 million08/05/2025$2.69$2.69$2.75$2.5652,807 shs$13.57 million08/04/2025$2.69$2.69$2.75$2.5652,807 shs$13.57 million08/01/2025$2.69$2.68-0.37%$2.96$2.6219,056 shs$13.52 million07/31/2025$2.69$2.69$2.97$2.6572,985 shs$13.57 million07/30/2025$2.93$2.69-8.03%$2.97$2.6572,985 shs$13.57 million07/29/2025$2.76$2.93+5.98%$2.97$2.7832,509 shs$14.75 million07/28/2025$2.76$2.76$2.96$2.6641,291 shs$13.92 million Get the Latest News and Ratings for ALVR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$2.77$2.84+2.53%$2.96$2.7837,511 shs$14.32 million07/24/2025$2.57$2.77+7.78%$2.97$2.53133,107 shs$13.97 million07/23/2025$2.39$2.57+7.53%$2.59$2.41148,226 shs$12.96 million07/22/2025$2.39$2.39$2.54$2.3740,606 shs$12.05 million07/21/2025$2.39$2.39$2.54$2.3740,606 shs$12.05 million07/18/2025$2.46$2.42-1.63%$2.52$2.35203,569 shs$12.20 million07/17/2025$2.40$2.46+2.50%$2.59$2.4036,951 shs$12.41 million07/16/2025$2.61$2.40-8.05%$2.60$2.3363,448 shs$12.10 million07/15/2025$2.43$2.61+7.41%$2.62$2.4633,885 shs$13.16 million07/14/2025$2.43$2.43$2.65$2.4268,547 shs$12.25 million07/11/2025$2.55$2.50-1.96%$2.64$2.4024,666 shs$12.61 million07/10/2025$2.58$2.55-1.16%$2.64$2.3665,226 shs$12.86 million07/09/2025$2.61$2.58-1.15%$2.64$2.5511,765 shs$13.01 million Related Companies ICCC Stock Price Chart ANL Stock Price Chart UNCY Stock Price Chart TELO Stock Price Chart VRCA Stock Price Chart HOWL Stock Price Chart ATNM Stock Price Chart ZIVO Stock Price Chart LTRN Stock Price Chart DTIL Stock Price Chart Receive ALVR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALVR) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AlloVir With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
